ARCHIVES

Increase In DCCR Grants May Not Be Possible Without Decreasing Quality, Committee Told

This article is from The Cancer Letter archive.

Vol. 04 No. 30 | July 28, 1978

Download PDF Visit The Full Archive

Related Articles

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

Missouri, Michigan Program As For Comprehensive Review

September 23, 1977

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009